Innovating Works

BIOTRIAL

Desconocido
PRISM 2: Psychiatric Ratings using Intermediate Stratified Markers 2 BIOTRIAL participó en un H2020: H2020-JTI-IMI2-2020-22-single-stage The current nosology of neuropsychiatric disorders provides a pragmatic approach to diagnosis and treatment choice but lacks reference to qu...
2021-05-19 - 2024-11-30 | Financiado
PRIME: Prevention and Remediation of Insulin Multimorbidity in Europe BIOTRIAL participó en un H2020: H2020-SC1-BHC-2018-2020 PRIME introduces the novel concept of insulin signalling as a key mechanism underlying the multimorbidity of major mental and somatic illnes...
2019-12-06 - 2024-12-31 | Financiado
PRISM: Psychiatric Ratings using Intermediate Stratified Markers Sofia ref. 115916 BIOTRIAL participó en un H2020: H2020-JTI-IMI2-2015-03-two-stage The current nosology of neuropsychiatric disorders allows for a pragmatic approach to treatment choice, regulation and clinical research. Ho...
2015-12-18 - 2019-09-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.